|
Acoramidis Clinical Trials
1 actively recruiting trial across 1 location
Also known as: AG10, ALXN2060
La Jolla, California1 trial
Acoramidis Transthyretin Amyloidosis Prevention Trial in the Young (ACT-EARLY) Study in Asymptomatic Carriers of a Pathogenic TTR Variant
University of California, San Diego (UCSD) - Medical Center
Phase 3
Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.
This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.